Ciliopathies are human diseases arising from defects in primary or motile cilia. The small G-protein Arl13B (ADP-ribosylation factor-like 13B) localizes to microtubule doublets of the ciliary axoneme and is mutated in Joubert syndrome. Its GDP/GTP mechanistic cycle and the effect of its mutations in patients with Joubert syndrome remain elusive. In the present study we applied high resolution structural and biochemical approaches to study Arl13B. The crystal structure of Chlamydomonas rheinhardtii Arl13B, comprising the G-domain and part of its unique C-terminus, revealed an incomplete active site, and together with biochemical data the present study accounts for the absence of intrinsic GTP hydrolysis by this protein. The structure shows that the residues representing patient mutations R79Q and R200C are involved in stabilizing important intramolecular interactions. Our studies suggest that Arg 79 is crucial for the GDP/GTP conformational change by stabilizing the large tworesidue register shift typical for Arf (ADP-ribosylation factor) and Arl subfamily proteins. A corresponding mutation in Arl3 induces considerable defects in effector and GAP (GTPase-activating protein) binding, suggesting a loss of Arl13B function in patients with Joubert syndrome.
INTRODUCTION
Cilia are small microtubule-based organelles emanating from almost every cell type of the human body [1] . Cilia fulfil crucial sensory functions and are a central compartment in a range of signalling pathways, including Sonic Hedgehog and Wnt signalling [2, 3] . Ciliopathies are diseases originating from the disruption of the structural integrity of cilia and/or their signalling pathways [4, 5] . Arl13B (ADP-ribosylation factor-like 13B) is one of several proteins mutated in Joubert syndrome [6] , a ciliopathy characterized by brain malformations with its characteristic molar tooth sign, combined with polydactyly and formation of kidney cysts [7] . Arl13B is considered a ciliary marker, as it exclusively localizes to the microtubule doublets of the ciliary axoneme. Gene knockouts in mouse [8] , Caenorhabditis elegans [9] and zebrafish [10, 11] confirmed its importance for cilia biology. Loss of Arl13B in mice leads to failure of B-tubule closure in the ciliary axoneme [8] and in C. elegans to mislocalization of various sensory receptors such as PKD2 (protein kinase D2), ODR-10, Tax2 and OSM9 [9, 12] . However its precise role and involvement in signalling pathways remain elusive.
Arl13B belongs to the Arf (ADP-ribosylation factor) subfamily of the Ras superfamily of small G-proteins. They cycle between an inactive GDP-bound and an active GTP-bound conformation [13, 14] . In the latter state they elicit cellular responses by binding to effector proteins, which are defined as binding specifically to the active state [15, 16] . Since GTP hydrolysis and GDP/GTP exchange are usually intrinsically slow, the cycle is regulated by GAPs (GTPase-activating proteins) and GEFs (guaninenucleotide-exchange factors) enhancing intrinsic rates by orders of magnitude [17, 18] . G-proteins of the Arf subfamily are structurally unique compared with other subfamilies of the Ras superfamily [19] . Their GDP/GTP transition shows an additional conformational switch called the interswitch toggle [20] . It is considered a communication device between the nucleotidebinding site and the amphipathic N-terminal helix present in all Arf/Arl proteins. In the inactive GDP-bound conformation, the N-terminal helix is bound in a hydrophobic pocket of the protein. Upon GTP binding the interswitch region shifts along the rest of the β-sheet by two residues such that the canonical interactions between switch I and switch II and the γ -phosphate become established [20, 21] . In the course of this process, the Nterminal helix is released from the pocket and becomes solvent-(or membrane-) exposed. The structural dynamics and energetics of this remarkable conformational change are still to be explored.
Arl13B is set apart from other G-proteins of the Arf subfamily in that it contains, in addition to the N-terminal G-domain, an extended C-terminus comprising a CC (coiled coil) and PRR (proline-rich region) [22] . A further major difference to other Arf family proteins is the absence of a catalytic glutamine/histidine residue in switch II. Although the nucleotide-binding ability of Arl13B has been described previously [6, 22] , the intrinsic GTPase activity for Arl13B has not been investigated up to date. Two missense mutations have been linked to Joubert syndrome [6] , R79Q in the G-domain and R200C in the CC region. Since these mutations seem not to impair localization of Arl13B to cilia [23] , the molecular basis of how they induce Joubert syndrome pathology continues to remain unclear. To further our understanding of the regulation of Arl13B GTPase activity and the effects of mutations, we used biochemical and high-resolution structural approaches to study Arl13B from Chlamydomonas rheinhardtii. Chlamydomonas is a unicellular green alga which moves by the means of two flagella. Since its flagella also consist of a microtubular axoneme similar to the ciliary axoneme, Chlamydomonas is often used as a model system to investigate proteins localizing to cilia/flagella or regulating the traffic inside this compartment [1, 24] .
In the present study we solved the structure of a construct of CrArl13B (Chlamydomonas rheinhardtii Arl13B) comprising the G-domain and part of the CC extension at 2.5 Å (1 Å = 0.1 nm) resolution. The structure enabled us to study and interpret the position and effects of its mutations in human patients. We found that Arg 200 and Arg 79 stabilize the 3D structure through participation in intramolecular interactions as part of an interaction network of Arf/Arl proteins. We find Arg 79 to be crucial for the conformational change of the interswitch toggle and that the Joubert mutation destabilizes the active state of the protein and is likely to cause a reduced affinity for its effectors.
MATERIALS AND METHODS

Plasmids and protein purification
CrArl13B (UniProt accession number A8INQ0) was amplified by PCR from a cDNA library from C. rheinhardtii CC-124 WT (wildtype) mt-[137c] [nit1, nit2, agg1] (a gift from Professor T. Happe, Department of Plant Biochemistry, Ruhr University Bochum, Bochum, Germany). In the present study shortened CrArl13B comprising amino acids 18-242 was used. The genes were cloned into pGexET (derivative of pGex4T-1) containing an Nterminal GST fusion followed by a thrombin, TEV (tobacco etch virus) and PreScission cleavage site (order as mentioned). Arl3 (UniProt accession number Q9WUL7) full length in pET20 was already available [25] . Respective CrArl13B R77Q , CrArl13B
R194C
and Arl3 R75Q mutants were generated by mutagenesis PCR. All proteins were expressed in Escherichia coli BL21 DE3 codon plus RIL cells at 25
• C following induction with 100 μM IPTG at 18
• C overnight. Purification was done using GSH-Sepharose columns (GE Healthcare) which were washed with wash buffer [75 mM Hepes, pH 7.5, 300 mM KCl, 5mM MgCl 2 , 3 mM 2-mercaptoethanol and 10 % (v/v) glycerol]. The GST-fusion proteins were eluted with elution buffer (wash buffer plus 20 mM GSH). Following cleavage with PreScission protease, overnight residual GST was removed by size-exclusion chromatography using a Superdex 200 26/60 (GE Healthcare). Arl3 proteins containing a C-terminal His tag were purified as described previously [25, 26] . The proteins were stored in buffer M containing 25 mM Hepes, pH 7.5, 150 mM KCl, 5 mM MgCl 2 , 1 mM DTE (dithioerythritol) and 5 % (v/v) glycerol.
Crystallization
Native CrArl13B was purified according to the procedure mentioned above. The protein was exchanged as described previously [25, 26] Table  S1 at http://www.biochemj.org/bj/457/bj4570301add.htm) were reproducible and usually appeared after 1-3 days, dissolved and appeared again after 8 days. They were flash frozen after 9 days in a cryo-solution containing the same constituents as the crystallizing condition supplemented with 20 % (v/v) glycerol. Data collection was done at the PXII-X10SA beamline of the Swiss Light Source (SLS), Villigen and P11 beamline at PETRA III at DESY campus, Hamburg, Germany. Data were indexed and processed with XDS [27] . Molecular replacement using different Arl structures was done with MOLREP and PHASER from the CCP4 package [28] . A model of the CrArl13B sequence generated by the PHYRE threader based on Arl2 (PDB code 1KSH [29] ) was used successfully in molecular replacement to solve the CrArl13B structure. The structure was refined using REFMAC5 [30] to the following resolution (Ramachandran statistics in parentheses): CrArl13B native to 2.5 Å (97.2 % favoured, 2.8 % allowed, 0 % outlier). For data and refinement statistics, see Supplementary Table S1. All the Figures were produced using PyMOL (http://www.pymol.org).
Atomic co-ordinates and structural factors have been deposited in the PDB under the accession code 4M9Q.
Analytical size-exclusion chromatography
The oligomerization state of Arl13B
WT and mutant proteins was investigated by analytical size-exclusion chromatography using a Superdex 200 10/300 column (GE Healthcare). A total of 0.5 mg of CrArl13B protein was incubated with a 10-fold molar excess of GDP or p[NH]ppG for 2 h at room temperature (25 • C). The mix was then applied to the size-exclusion chromatography column and eluted with 1 column volume of buffer M. The elution profile was recorded and eluted fractions were analysed by SDS/PAGE.
Measurement of GTP hydrolysis by HPLC
Briefly, 100 μM GTP and 100 μM CrArl13B
WT -GTP were incubated in buffer M at room temperature. Aliquots (30 μl) were taken at 0, 30, 60, 120, 180, 240 and 360 min. The protein was denatured by incubation for 5 min at 95
• C and the nucleotide content of the supernatant was determined by HPLC measurements on a C 18 column. GTP hydrolysis was also monitored under multiple turnover conditions by mixing 100 μM GTP with 1 μM CrArl13B
WT . The mutant proteins R77Q and R194C were also measured under single and multiple turnover conditions. 31 P and 1 H NMR spectra were recorded with a Bruker AVANCE-500 NMR spectrometer operating at a 31 P frequency of 202 MHz. Measurements were performed in a 31 P selective 10-mm probe by using 8-mm Shigemi sample tubes at various temperatures. CrArl13B proteins (approximately 1 mM solutions) in 25 mM Hepes/NaOH, pH 7.5, 150 mM KCl, 5 mM MgCl 2 and 1 mM DTE contained 10 % 2 H 2 O to get a lock signal. 2,2-Dimethyl-2-silapentane-5-sulfonate (0.2 mM) was added to calibrate the spectra by indirect referencing according to Maurer and Kalbitzer [31] . Pulses of 70
NMR experiments
• were applied with a total repetition time of 7 s. Protons were decoupled by GARP sequence during data acquisition. The resonance assignment was transferred from Meierhofer et al. [32] . Additional 1D NOESY 1 H NMR spectra of the same samples were recorded on a Bruker AVANCE 600 NMR spectrometer at 278 K.
Affinity measurements
Arl3
WT or mutant proteins were loaded with mant (Nmethylanthraniloyl)-GDP or mant-p[NH]ppG (Pharma Waldhof) overnight at 12
• C by incubation with a 1.5-fold molar excess of nucleotide and purified the following day on a desalting rheinhardtii (Cr) (UniProt accession number A8INQ0). Dependent on their degree of conservation, residues are highlighted in dark and light grey. The G1-G5 motifs characteristic for the G-domain, switch I and II, and the secondary structure elements of CrArl13B are shown below and above the alignment respectively. Black arrows indicate residues mutated in Joubert Syndrome. Secondary structure elements above the sequence are from the structure determined in the present study (except for the rest of α6; see text).
column in buffer M [25] . Nucleotide loading was determined by HPLC measurements on a C 18 column. Polarization data was recorded with a Fluoromax-4 spectrophotometer (Jobin Yvon), with excitation and emission wavelengths of mant-labelled nucleotides at 366 and 450 nm respectively. Binding affinities of Arl3 WT and mutant proteins to HRG4 (human retinal gene 4), BART (binder of ARL2) and RP2 (retinitis pigmentosa 2) were measured by monitoring the polarization signal during titration of 1 μM Arl3 loaded with the respective nucleotide with increasing amounts of HRG4, BART or RP2 at 20
• C in buffer M. The data points obtained were fitted to a first-order reaction using Grafit5 (Erithacus software) to obtain the dissociation constant K d .
Determination of dissociation rates
CrArl13B (10 μM) was titrated with 1 μM mant-GDP, mantp[NH]ppG, mant-ADP or mant-ATP in buffer M at 20
• C. When the exchange reached equilibrium, reflected by a plateau in the polarization signal, the dissociation of mant-labelled nucleotide was induced by the addition of 400 μM unlabelled nucleotide, GDP, p[NH]ppG, ADP or ATP respectively. The exchange was followed by monitoring the polarization signal (for wavelength see above). Single exponential functions were fitted to the data using Grafit5 (Erithacus software) to obtain the k off values.
Tryptophan fluorescence
Fluorescence data was recorded with a Fluoromax-4 spectrometer (see above) with excitation and emission wavelengths of tryptophan at 290 and 340 nm respectively as reported previously [33] . CrArl13B (1 μM) WT or mutant proteins were preloaded with GDP and their tryptophan fluorescence was monitored before and after the addition of either 10 μM GDP or GTP at 20
• C in buffer M.
RESULTS
Expression and characterization of Arl13B from C. reinhardtii
Since human Arl13B turned out to be refractory to recombinant expression, we wondered whether we could identify and work with a Chlamydomonas homologue, since this organism is frequently used as a model system for ciliary biology [1, 24] . Chlamydomonas CrArl13B, similar to the human protein, consists of a G-domain, a CC domain and a PRR ( Figure 1A ). The major difference between the two homologues is that the PRR is considerably (99 amino acids) longer in the case of CrArl13B (Supplementary Figure S1 at http:// www.biochemj.org/bj/457/bj4570301add.htm). On expression of full-length CrArl13B in E. coli, the protein was consistently C-terminally degraded to smaller more stable constructs, most likely due to the non-compactness of the PRR, for which no secondary structure elements can be predicted. We succeeded in the purification of a smaller stable construct comprising the Gdomain and part of the CC region ranging from amino acid 18 to 242, denoted CrArl13B ( Figure 1 ). Within amino acids 1-242, Chlamydomonas and human Arl13B are 39 % identical (57 % similar) and are predicted to form similar secondary structure elements. They also contain the characteristic sequence motifs of the G-domain ( Figure 1B ).
The protein purified from E. coli contains equimolar amounts of bound nucleotide in a 20 % GDP to 80 % GTP ratio as determined by HPLC measurements, indicating that the protein is active and has a reasonably high affinity to guanine nucleotides ( Figure 2A ). To see whether the bound nucleotide is functional and can be exchanged in the absence of a GEF, exchange kinetics were monitored by fluorescence polarization measurements ( Figure 2B ). Addition of 10 μM CrArl13B to 1 μM mant-labelled GDP or p[NH]ppG led to an increase in polarization indicating binding of the fluorescent guanine nucleotides. The rate of binding is identical as would be expected if the reaction is ratelimited by the release of bound nucleotide. The mant-labelled nucleotides bound to the protein could then be exchanged by addition of an excess of unlabelled nucleotide monitored as a decrease in polarization ( Figure 2B ). We observed a difference in the dissociation reaction, with mant-p[NH]ppG being released approximately 5-fold slower than mant-GDP. Since affinity in most cases is dictated by the dissociation rate [13] , we can assume that binding affinities of the nucleoside triphosphate is approximately 5-fold higher than that of the diphosphate. No increase in fluorescence polarization was observed upon addition of 10 μM CrArl13B to 1 μM mant-labelled ADP or ATP nucleotides, confirming specificity of CrArl13B for guanine, but not adenine, nucleotides ( Figure 2B ).
Despite being able to purify small amounts of human Arl13B proteins of varying length and stability, we were not able to observe nucleotide bound to the purified protein nor could we detect any specific and, more importantly, reversible nucleotide exchange. The recombinant human protein bound unspecifically and irreversibly to all nucleotides tested suggesting a lack of proper folding (results not shown).
Structure of Arl13B from C. rheinhardtii
No crystals could be obtained for CrArl13B bound to GTP or GDP. However, CrArl13B bound to the non-hydrolysable GTP analogue p[NH]ppG crystallized in space group P2 1 2 1 2 1 and diffracted to 2.5 Å resolution (Supplementary Table S1 ). The asymmetric unit contained three Arl13B-p[NH]ppG monomers (Supplementary Figure S2 at http://www.biochemj.org/bj/457/bj4570301add.htm) in which the α4 and α5 helices and the β6 strand of one monomer are contacting the α2 helix/switch II and the β2 strand/switch I of a neighbouring monomer. Each monomer is turned by 45
• respective to the next monomer. Further packing produces a fibre-like structure of molecules in the crystal. To investigate the possibility that the packing is of any biochemical/physiological significance, we analysed a different crystal form. Crystals of space group C222 1 , which diffracted to approximately a 3.5 Å resolution, contained an identical arrangement of three monomers per asymmetric unit (results not shown) which, however, showed no fibre formation as observed in P2 1 2 1 2 1 . Gel-filtration experiments show that, compared with gel filtration standards, CrArl13B elutes as a monomer in solution (see also below, Figure 3C ).
CrArl13B contains a typical G-domain fold with a six-stranded β-sheet surrounded by five α-helices ( Figure 3A ). The α6 helix, which is part of the CC region, emanates from the G-domain. For reasons not obvious from the sequence, it forms a sharp 90
• turn relative to the α5 helix of the G-domain and is apparently held in place by intramolecular interactions (Supplementary Figure  S3A at http://www.biochemj.org/bj/457/bj4570301add.htm). The contact between the G-domain and the α6 helix is formed by two loops, one connecting helix α2 to β4 and the other linking helix α3 to β5. The loop linking α3-β5 seems to form more contacts between the G-domain and the α6 helix, with Arg 194 playing a central role (Supplementary Figure S3A, zoom) . The loop connecting α2-β4 is adjacent to α2 which in Arf/Arls belongs to switch II moving upon the GDP-GTP transition. The α2-β4 loop itself, however, does not move upon the GDP-GTP transition as compared with other Arf/Arl structures. Despite the construct comprising amino acids 18-242, only amino acids 18-212 are visible in the electron density. Since the rest of the construct is predicted as an α-helix and there is enough space in the crystal for the extension of α6, we suspect that the missing residues are not visible due to intrinsic mobility of the C-terminal end of the helix. This is further supported by the observation that in crystals of space group C222 1 , amino acids 18-224 are now visible and that in both crystals helix α6 is pointing away in a straight line from the G-domain and is not involved in any crystal contacts, most likely adding to its flexibility. The residues in question are, however, present on the protein to be crystallized since no further degradation of CrArl13B was observed during purification and handling.
The active site of CrArl13B lacks a catalytic glutamine residue
A close look at the active site of CrArl13B shows that it contains all conserved residues required for guanine nucleotide binding in canonical orientation, such as the P-loop, a threonine residue in switch I, DxxG in switch II, and the NKxD and SAK motifs required for guanine specificity (Figures 1B and 3A) . The location and conformation of p[NH]ppG is canonical. An Mg 2 + ion and water molecules can be seen in the active site ( Figure 3A) . The Mg 2 + is co-ordinated by the β-and γ -phosphate of the nucleotide, the side-chain oxygens of Thr 33 (P-loop) and Thr 52 (switch I) and two water molecules.
Analysis of the sequence had suggested a failure of Arl13B to hydrolyse GTP, as glutamine, the residue following the consensus org/bj/457/bj4570301add.htm). This residue is crucial for GTP hydrolysis as it stabilizes the position of the nucleophilic water molecule. In the structure we find no other residue that could potentially be involved in catalysing phophoryl transfer. The absence of intrinsic GTP hydrolysis was confirmed by HPLC measurements under single and multiple turnover conditions ( Figure 3B ). In contrast with observations by Hori et al. [22] , it can be excluded that a catalytic residue is inserted in trans into the active site from neighbouring monomers identified in the structure, suggesting that Arl13B might not be a GAD, a G-protein activated by dimerization [34] . GTP hydrolysis by dimerization of CrArl13B can probably be ruled out as the protein elutes as monomer of 25 kDa in analytical gel filtration independently of the nature of the bound nucleotide ( Figure 3C ).
The Joubert mutations Arg 77 and Arg
194
Considering the expected close structural homology based on the overall sequence conservation, CrArl13B can most likely be used as a model to investigate the human patient mutations R79Q and R200C, which are fully conserved between organisms as indicated in Figure 1(B) (Supplementary Figure S1) . protein. Arg 77 is located on the α2 helix of the G-domain and is orientated towards the interior ( Figure 4A and Supplementary Figure S3B ). It forms a salt bridge network with Asp 28 of the P-loop and Arg 101 and Glu 104 of the α3 helix. Considering the large conformational change in the GDP-GTP transition of the switch II region of all Arf and Arl proteins [19, 20] , it appears that these intramolecular salt bridges stabilize particularly the GTP-bound protein conformation and the position of switch II (Supplementary Figure S3B) . The bridging nitrogen (Nε) of Arg 77 further establishes a hydrogen bond to the backbone oxygen of Gly 72 of the DxxG motif. This glycine residue also forms the canonical NH main chain interaction with the γ -phosphate (Supplementary Figure S3B) . Arg 194 is located within the CC region on the α6 helix ( Figure 4B ). The guanidinium group of Arg 194 forms a hydrogen bond to the main chain oxygen of Arg 119 via the terminal nitrogen. There is an additional salt bridge between Nω of the Arg 119 guanidinium group and the bridging nitrogen Nε of the guanidinium group of Arg 194 . These interactions appear to stabilize the position of the α6 helix relative to the G-domain, which makes a sharp 90
• turn relative to helix α5 (see above, Supplementary Figure S3A) . Arg 77 and Arg 194 mutations to glutamine and cysteine respectively, as found in patients with Joubert syndrome in analogous positions, are expected to disrupt the intramolecular interactions. We thus introduced the R77Q and R194C substitutions into CrArl13B and could purify soluble functional proteins in both cases (Supplementary Figures S5C and S5D at http://www.biochemj.org/ bj/457/bj4570301add.htm). Similarly to the WT protein, both mutants lack GTP hydrolysis (Supplementary Figure S5B) . 31 P-NMR spectroscopy using the bound nucleotide as a probe is a sensitive method to detect structural changes in the active centre of Ras superfamily proteins [35] . The most dominant factors determining the obtained 31 P chemical shifts are the conformational strain and electric field effects polarizing the phosphate oxygens of the nucleotide. Long-range effects due to structural rearrangement can also lead to changes in the anisotropy of the magnetic susceptibility, e.g. ring current effects of aromatic side chains. Although chemical shift changes cannot be interpreted in a simple way, the local chemical environment of the observed nucleus must be different. Table S2 ). Additional line broadening in these experiments could principally be due to dimerization, leading to an increase of the rotational correlation time of the complex or the result of chemical exchange processes. Since the 1 H NMR data of the same inactive and active Arl13B complexes did not show any indications for dimerization (results not shown), these results can be explained by conformational exchange processes in the WT which are not observed in the R194C mutant or, if they exist, then exchange should exhibit much higher interconversion rates. Apart from some differences in line-width, which again indicates a chemical exchange process in the R77Q mutant, no chemical shift changes could be detected for GDP bound to the proteins, which suggests that these mutational changes have much more specific effects for the active conformation of CrArl13B (Supplementary Figure S5A) .
Analytical gel filtration shows both R77Q and R194C eluting as monomers of approximately 25 kDa independently of their nucleotide state ( Figure 5A ). Nucleotide affinities could not be determined as the nucleotide-free protein precipitated. As an indirect measure of affinities, dissociation rates (k off ) were measured for CrArl13B
WT , CrArl13B R77Q and CrArl13B
R194C
bound to either mant-GDP or mant-p[NH]ppG ( Figure 5B ). The exchange of the mant-labelled nucleotide to unlabelled nucleotide was followed by the change in fluorescence polarization over time.
The k off values were determined by fitting a single exponential function to the curves. No major difference can be detected in the dissociation rates for GDP between WT and the mutants R77Q and R194C ( Figure 5B , left-hand panel and table) . In contrast, the k off value obtained for p[NH]ppG is increased by approximately 30-fold for R77Q ( Figure 5B , right-hand panel and table) and 10-fold for R194C. This suggests that the structural changes are transmitted to the GTP-binding site in Joubert syndrome mutants.
Arg 77 is essential for the stability of the GTP-bound conformation and interaction with effectors
A DALI search shows Arl2, Arl3 and Arf1 to be the closest structural homologues of CrArl13B. An overlay of CrArl13B with [39] ), Arf1-GTP (PDB code 2J59 [48] ) and Arl2-GTP (PDB code 3DOE [44] ) is shown on the left-hand side, the zoom into switch II on the right-hand side. The salt bridge interaction network between aspartate (P-loop), arginine (α3 helix) and arginine (α2 helix) residues can be found in all Arl/Arf structures. Figure S4) . Asp 28 in the P-loop corresponds to residue Gly 12 in Ras, where every mutation of Gly 12 including aspartate blocks GAP-mediated GTP hydrolysis and makes Ras an oncogene [36] . Apparently the fixation of the aspartate residue away from the active site by the salt bridge network allows the ArfGAPs to insert its arginine finger and function properly [37] . Only Glu 104 in α3 of CrArl13B is replaced by different amino acids in other Arf/Arl proteins. Alignment of a few representative G-proteins of each subfamily showed that the aspartate residue of the P-loop, the arginine residue in α2 and the arginine residue in α3 are highly conserved only in the Arf subfamily except Arl8 (Supplementary Figure S4) . Hence, the three residues and their interactions seem to constitute a critical part of the Arf subfamily function.
In order to better understand the role of Arg 77 in the GDP/GTP structural transition, we superimposed structures of Arl3-GDP [38] with Arl3-p[NH]ppG [39] (Figure 6B ). Arl3 was chosen since no crystals could be obtained for CrArl13B-GDP and no structure of Arl2-GDP is available in the PDB. Arg 75 in Arl3 is the residue corresponding to Arg 77 in CrArl13B. The overlay shows that, upon the GDP/GTP structural transition, the α2 helix as part of switch II undergoes a major conformational change such that the guanidinium group of Arg 75 undergoes a movement of approximately 7.6 Å ( Figure 6B) . Similar large conformational changes of switch II are documented by e.g. the structures of Arl3-p[NH]ppG (PDB code 3BH6 [39] ) and Arf6-GTP (PDB code 2J5X [21] ) compared with their GDP-bound structures (PDB codes 1FZQ [38] and 1E0S [33] respectively). Intriguingly, the α2 helix is connected to β3, which together with β2 forms what is called the interswitch toggle of Arf and Arl proteins. Tilting of α2 towards the active site consequently seems to push down the interswitch toggle. Movement of the interswitch toggle away from the active site usually is linked to the ejection of the N-terminal helix.
This large conformational change as a result of the GDP/GTP transition can be monitored by a similar large change in tryptophan fluorescence as shown for other Arf proteins. A tryptophan residue in helix α2 of switch II was shown to change its conformation and is even more excluded from solvent upon the GDP/GTP structural transition of Arf proteins [20, 33] . CrArl13B also possesses a tryptophan residue in switch II, apart from a second tryptophan residue in helix α5. WT and mutant CrArl13B were preloaded with GDP. The addition of GTP leads to a considerable 1.6-fold increase in tryptophan fluorescence for the WT (Figure 6C ), suggesting the same toggle movement characteristic for the Arf subfamily. The Joubert syndrome mutations R77Q and R194C show a decreased amplitude of tryptophan fluorescence change, only 1.2-or 1.1-fold respectively upon addition of GTP ( Figure 6C ). This suggests, as expected, that although the mutants do bind GTP or GTP analogues, the transition to and/or the stability of the active conformation is impaired in these mutants.
Considering the large conformational change in the switch region observed for Arf/Arl proteins and its stabilization by the salt bridge network, we speculated that mutation of Arg 77 in Arl13B will result in impaired effector binding and N-terminal helix release. In the absence of any clearly defined Arl13B effector, we investigated the interaction of Arl3 and the corresponding R75Q mutant with the two effectors HRG4/Unc119a and BART by fluorescence polarization. Determination of the dissociation constant (K d ) for interaction of Arl3
WT and Arl3 R75Q with the effectors shows that binding is dramatically impaired. HRG4/Unc119 binds to switch I and II and BART contacts the N-terminal helix in addition to the switch regions of Arl (Supplementary Figure S6 at http://www.biochemj.org/bj/457/bj4570301add.htm). In both cases the affinity is reduced by approximately 10-to 1000-fold for R75Q compared with WT ( Figure 7A ). To further confirm the analogy between Arl3 and Arl13B and the Joubert syndrome mutation R77Q, the k off value for Arl3 R75Q bound to p[NH]ppG also increases, whereas it has no effect on GDP dissociation ( Figure 7B) . Furthermore, the Arl3-specific GAP RP2 also binds with approximately 100-fold reduced affinity to Arl3 R75Q ( Figure 7A ) with consequently impaired GTP hydrolysis (results not shown). Thus these data suggest that the ability to adopt the active conformation is severely affected by this mutation.
DISCUSSION
The Arf/Arl subfamily sets itself apart within the Ras superfamily in possessing an interswitch toggle linked to an N-terminal amphipathic helix, which in many members is lipid modified and thought to establish membrane interactions [19] . The structural determinants of that extremely large conformational change remain to be explored. Apart from Arl3 and Arl6, Arl13B is one of the three Arl proteins found in the proteome of ciliated organisms. Both Arl6 [40, 41] and Arl13B [6, 8, 42] have been reported to be mutated in human disease, causing the ciliopathies Bardet Biedl Syndrome and Joubert Syndrome respectively. Knockout of Arl3 in mice causes severe defects in the function of photoreceptors. Whereas the role of Arl3 in ciliary trafficking of prenylated and myristoylated proteins is beginning to be explored [43] , the role of Arl13B and the regulation and function of its GTPase cycle in cilia is unknown. In light of this the consequences of the described disease mutations of Arl proteins in ciliopathies need to be investigated.
The present study aimed to understand the mechanistic consequences of the Arl13B mutations R79Q and R200C that cause Joubert syndrome [6] . We are rather confident that the results from Chlamydomonas can be extrapolated to the human protein. We thus show that the residues analogous to the mutations R79Q and R200C are structurally important for the functional integrity of the Arl13B G-domain. Arg 200 seems to link the long α6 helix of the CC region to the G-domain. We speculate that the R200C mutation destabilizes the position of helix α6 of the CC region relative to the G-domain. It suggests that a fixed orientation of the CC region is crucial for the function of Arl13B. On the basis of the structure of CrArl13B we identified Arg 79 to be critical for establishing the proper GTP-bound conformation of Arl13B needed for effector binding and interaction with a GAP protein. Arg 79 participates in an extended salt bridge network in the active state. We find this interaction network involving Arg 79 to be a characteristic of the entire Arf/Arl subfamily. Previously it has been suggested that wDvGGqxxxRxxW (G3 motif, switch II) is a signature sequence for Arl proteins that toggle [20] , however the importance of this arginine residue has not been investigated. Comparison of the GDP-and GTP-bound structures of Arl3 (and others) shows that this arginine residue undergoes a drastic translocation upon activation.
Using Arl3 as example, we demonstrate that mutation of the arginine residue to glutamine indeed impairs effector binding as well as binding of Arl3 to its GAP RP2. Since small G-proteins require an intact switch II region for interaction with effectors and assuming that as in Arl3 the Arg 77 mutation disturbs the interaction with its cognate GAP, we may assume that the Joubert syndrome mutants are mostly GTP-bound. Nevertheless these mutants are loss-of-function mutants due to the lack of effector binding. In case of Arl3, an effector interaction, e.g. with BART involving the N-terminal helix of Arl3 additionally to its switches [44] seems even more severely affected by this mutation. Therefore the inability to stabilize switch II appears to disable the efficient release of the N-terminal helix upon the GDP/GTP transition. The GDP nucleotide-exchange reaction for WT and mutant Arl13B are similarly slow with a half-life in the order of 6-12 min, which suggests that Arl13B might require a GEF for loading with GTP. Arl13B R79Q becomes localized to cilia in the same way as the WT protein [23] . Therefore we can conclude that transport of Arl13B to cilia might take place independently of its GTPase activity, i.e. the hydrolysis of GTP and/or binding to an upstream regulator or downstream effector. Considering that GTP binding to Arl13B
R200C is also weakened as in the R79Q mutant, we would assume that this mutation, which probably destabilizes the position of the long CC helix, might be similarly affected in its ability to bind the effector and/or GAP. R200C localizes normally to cilia [23] , but as R79Q it cannot rescue the ciliogenesis defect caused by Arl13B
WT deletion. In the present study it has been demonstrated that the CC region and the PRR, which are C-terminal to α6, are required, in addition to the potential palmitoylation [9, 42] of the N-terminus, to be targeted to the cilium [10, 22, 42] .
The question of what function the GTP hydrolysis of Arl13B actually fulfils depends on the future identification of its regulators. The absence of a catalytic residue in the active site of Arl13B and the lack of dimerization for a construct comprising the G-domain and part of the CC region suggest that regulation of Arl13B GTPase activity indeed is in need of a GAP, supposedly one that inserts an asparagine or a glutamine residue into the active site as shown for RapGAP [45, 46] and RabGAP [47] . It is tempting to speculate that GTP hydrolysis might be linked to a conformational change extending to its C-terminal CC and PRR or the regulation of IFT (intraflagellar transport). The latter is suggested by various reports of IFT-B and IFT-A dissociation upon Arl13B deletion [9, 42] .
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Figure S6 Arl effector interactions
(A) Crystal structure of Arl2-GTP-BART (PDB code 3DOE [2] ). BART binds to the N-terminal helix of Arl2-GTP and contacts switch I (light blue) whereas minor contacts are made to switch II. (B) Crystal structure of Arl2-GppNHp-HRG4 (PDB code 4GOK [3] ) shows that HRG4 is interacting with switch I and II.
